Literature DB >> 14656529

Development of a fluorescence polarization assay to screen for inhibitors of the FtsZ/ZipA interaction.

Cynthia Hess Kenny1, Weidong Ding, Kerry Kelleher, Susan Benard, Elizabeth Glasfeld Dushin, Alan G Sutherland, Lidia Mosyak, Ronald Kriz, George Ellestad.   

Abstract

A fluorescence polarization competition assay has been developed to screen for inhibitors of the Escherichia coli FtsZ/ZipA protein-protein interaction. A previously published X-ray costructure demonstrated that a 17-amino-acid peptide, corresponding to FtsZ C-terminal residues 367-383 (FtsZ(367-383)), interacts with the C-terminal FtsZ binding domain of ZipA (ZipA(185-328)). Phage display was employed to identify a unique but related peptide which when further modified and labeled was shown to have a higher affinity to ZipA(185-328) than the FtsZ(367-383) peptide and binds to the same site. This peptide had a six fold increase in fluorescence polarization upon binding to ZipA(185-328) compared to a two fold increase for the FtsZ(367-383) fluorophore. As a result, assay parameters using the phage display peptide were further optimized and adapted for the high-throughput screen. A high-throughput screen of 250,000 compounds identified 29 hits with inhibition equal to or greater than 30% at 50 microg/ml. An X-ray costructure of a promising small molecule in this library complexed with ZipA(185-328) (KI=12 microM) revealed that the compound binds to the same hydrophobic pocket as the FtsZ(367-383) peptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656529     DOI: 10.1016/j.ab.2003.08.033

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  15 in total

1.  Bacterial division proteins FtsZ and ZipA induce vesicle shrinkage and cell membrane invagination.

Authors:  Elisa J Cabré; Alicia Sánchez-Gorostiaga; Paolo Carrara; Noelia Ropero; Mercedes Casanova; Pilar Palacios; Pasquale Stano; Mercedes Jiménez; Germán Rivas; Miguel Vicente
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

Review 2.  Cell-based assays for high-throughput screening.

Authors:  W Frank An; Nicola Tolliday
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

Review 3.  Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

Authors:  Duncan E Scott; Andrew R Bayly; Chris Abell; John Skidmore
Journal:  Nat Rev Drug Discov       Date:  2016-04-11       Impact factor: 84.694

4.  Dynamic interaction of the Escherichia coli cell division ZipA and FtsZ proteins evidenced in nanodiscs.

Authors:  Víctor M Hernández-Rocamora; Belén Reija; Concepción García; Paolo Natale; Carlos Alfonso; Allen P Minton; Silvia Zorrilla; Germán Rivas; Miguel Vicente
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

5.  Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.

Authors:  William P Bozza; Kun Yang; Jialiang Wang; Zhihao Zhuang
Journal:  Anal Biochem       Date:  2012-04-20       Impact factor: 3.365

Review 6.  Discovery of anti-TB agents that target the cell-division protein FtsZ.

Authors:  Kunal Kumar; Divya Awasthi; William T Berger; Peter J Tonge; Richard A Slayden; Iwao Ojima
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

Review 7.  Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.

Authors:  Andrew F Voter; James L Keck
Journal:  Adv Protein Chem Struct Biol       Date:  2017-08-24       Impact factor: 3.507

8.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

9.  Methodology to probe subunit interactions in ribonucleotide reductases.

Authors:  A Quamrul Hassan; Yongting Wang; Lars Plate; JoAnne Stubbe
Journal:  Biochemistry       Date:  2008-12-09       Impact factor: 3.162

10.  Druggable protein interaction sites are more predisposed to surface pocket formation than the rest of the protein surface.

Authors:  David K Johnson; John Karanicolas
Journal:  PLoS Comput Biol       Date:  2013-03-07       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.